HLA-C and neoplasm: The biological mechanisms of primary resistance to ICIs are thought to be based on 2 categories: intrinsic mechanisms of the tumor cell, and extrinsic mechanisms of the tumor microenvironment.[2] Intrinsic mechanisms include low tumor mutation burden associated with fewer neoantigens that tumor-specific T cells can target and a decreased efficiency of antigen-presenting mechanisms of tumor cells missing MHC molecule.